Back to Trials
NCT05701254RecruitingAccepts Healthy Volunteers

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

Creighton University

Start Date

6/18/2019

Completion Date

1/1/2025

Summary

Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone tissue mechanical defects. The potential benefits to participants would be knowledge gained about their bone density and the results of laboratory tests. On a wider scale, there may be general benefits to society because the knowledge gained from this study may help better understand the effects of diabetes on bone health

Detailed Description

The investigators will enroll 40 female, postmenopausal, patients with T1DM, fracturing or non-fracturing, who are age 50 and over, and have had diabetes for more than ten years. The investigators will perform 2 transiliac (hip bone) biopsies on each subject, one for mechanical testing, tissue analysis of AGEs, enzymatic crosslinks and bone tissue-bound water in cortical bone, and the other for histomorphometry and high-resolution 3D imaging in trabecular bone. A matched, non-diabetic, healthy control will be enrolled at the time each T1DM is enrolled.

Eligibility Criteria

Age Range: 50 years to No maximum

Inclusion Criteria: Criteria for enrollment of female diabetics 1. No chronic disease diagnoses that may affect bone, as confirmed by the PI. 2. Normal clinical history, physical, and clinical laboratory exam (except for usual complications of a 10+-year diabetic, i.e., \~minimal neuropathy or retinopathy, known, but asymptomatic mild vascular disease, etc.) 3. Glomelular Filtration Rate (GFR) \>45 ml/min (Renal Association lower limit for "mild" kidney failure). 4. Willingness to sign a consent form. 5. Willingness to undergo a transilial bone biopsy incision that yields 2 bone specimens. 6. No abnormalities in clinical blood chemistry measurements (small, age-related decreases in GFR, will be permitted). 7. Caucasian Criteria for each non-diabetic subject, compared to their matched diabetic: 1. Dual-energy x-ray absorptiometry (DXA) measures (BMD, gm/cm) must be within +/- 15% in total hip. 2. Body mass index (BMI) must be within +/-10%. 3. Age must be within +/- 5 years. 4. Caucasian Exclusion Criteria: 1. Women who have had Type 1 diabetes for less than 10 years. 2. Non-insulin dependent Type 1 diabetic. 3. Less than 50 years old. 4. Less than 5 years post menopausal.

Interventions

PROCEDURE

Transilial bone biopsy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Type 1 DiabetesOsteopeniaBone LossFractures, Bone

Locations

Creighton University Osteoporosis Research Center

Omaha, Nebraska 68122

United States